Olimel N7 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7 provides amino acid supplementation that supports several clinical nutrition pathways.

• Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass.
• Post‑operative recovery: assists in wound healing and tissue regeneration.
• Chronic kidney disease on dialysis: supplies essential amino acids lost during treatment.
• Severe burns or trauma: contributes to increased protein requirements for repair.
• Long‑term parenteral nutrition: maintains adequate amino acid profile when enteral intake is insufficient.

• The amino acids in Olimel N7 are absorbed via intestinal transporters and enter the systemic circulation, where they serve as substrates for protein synthesis, act as precursors for neurotransmitters and metabolic intermediates, and support nitrogen balance. By providing a balanced profile of essential and non‑essential amino acids, the product helps meet increased metabolic demands in catabolic states.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild gastrointestinal discomfort.
• Diarrhea: loose stools, often transient.
• Abdominal cramping: intermittent stomach pain.
• Metallic taste: temporary alteration of taste perception.
• Headache: mild, self‑limiting.
• Skin redness at oral mucosa: mild irritation.

Serious or Rare Side Effects

• Hypersensitivity reaction: rash, itching, or swelling.
• Anaphylaxis: severe, potentially life‑threatening allergic response.
• Metabolic acidosis: rare disturbance in acid‑base balance.
• Hyperammonemia: elevated ammonia levels in susceptible individuals.
• Severe electrolyte imbalance: uncommon but possible with high‑dose regimens.
• Hepatic dysfunction: rare liver enzyme elevation.

When prescribing Olimel N7, clinicians should consider patient‑specific factors and monitor for potential complications.

• Renal impairment: adjust dosage based on kidney function.
• Hepatic disease: use with caution in liver dysfunction.
• Pregnancy and lactation: evaluate risk‑benefit before use.
• Pediatric use: limit to age‑appropriate dosing under supervision.
• Concomitant medications: review for possible amino‑acid interactions.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid supplements can influence the pharmacokinetics of certain drugs and should be reviewed for compatibility.

Major Interactions (Avoid)

• Levodopa: reduced absorption may diminish therapeutic effect.
• MAO inhibitors: risk of hypertensive crisis with excess tyramine.
• Thyroid hormone replacement: altered absorption leading to dosing variability.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): possible changes in plasma protein binding.
• Antibiotics (e.g., tetracycline): chelation reducing antibiotic efficacy.
• Iron supplements: decreased amino‑acid absorption when co‑administered.